T1	Participants 76 163	deceased-donor kidney transplant recipients at specified risk of delayed graft function
T2	Participants 199 210	multicenter
T3	Participants 511 519	CALLISTO
T4	Participants 549 560	multicenter
T5	Participants 580 655	Deceased-donor kidney transplant patients at protocol-specified risk of DGF
T6	Participants 702 734	immediate everolimus, IE; n = 65
T7	Participants 747 777	delayed everolimus, DE; n = 74
T8	Participants 1479 1496	DGF-risk patients
